Medicalgorithmics S.A.

Medicalgorithmics S.A. is a pioneering medical technology company in the field of cardiac monitoring, known for its non-invasive mobile ECG and arrhythmia diagnostic technology, PocketECG. Founded in 2005 and headquartered in Poland, the company is focused on AI-powered and noninvasive solutions for cardiac arrhythmia within the Health Care industry. With a strong emphasis on science and innovation, Medicalgorithmics collaborates closely with healthcare professionals to reduce costs, streamline clinical workflows, and enhance patient care. The company's AI algorithms aim to accurately detect and diagnose diseases at an early stage, thereby improving treatment outcomes. Medicalgorithmics' innovative portfolio encompasses software, artificial intelligence, and cloud-based solutions for healthcare systems, physicians, and medical technology companies. Their flagship products include the PocketECG system, FDA-approved TechBot, and DeepRhythm software platforms for cardiac arrhythmia. Notably, they have also developed the noninvasive AI-powered VCAST (Virtual Cardiac Stress Test) technology, which has the potential to revolutionize the diagnosis and treatment of coronary artery disease. The company received a PLN2.00M Seed Round investment on 01 January 2007 from New Europe Ventures, LLC. Medicalgorithmics has been listed on the Warsaw Stock Exchange since 2014. As a global provider of cutting-edge cardiac solutions, Medicalgorithmics is poised for further advancements in the realm of cardiac arrhythmia diagnosis and treatment.